ACTA2 and idiopathic pulmonary fibrosis: Inhibiting miR-33 in PCLS isolated from patients with IPF not only decreased the expression of ACTA2 and collagen, but also altered the expression of genes known to be expressed in profibrotic macrophages, suggesting an effect on this population.